asthma
chronic
inflammatori
airway
diseas
character
bronchial
hyperrespons
wide
rang
stimuli
recurr
episod
wheez
breathless
chest
tight
cough
associ
revers
airflow
limit
import
medic
social
econom
implic
asthma
depend
larg
epidemiolog
impact
million
peopl
worldwid
affect
diseas
whose
preval
rise
especi
industri
countri
alarm
number
prompt
huge
invest
financi
human
resourc
aim
elucid
pathogen
mechan
underli
asthma
well
develop
new
effect
antiasthma
treatment
current
clinic
experiment
evid
impli
two
essenti
compon
asthmat
phenotyp
includ
bronchial
inflamm
mainli
involv
lymphocyt
eosinophil
mast
cell
airway
remodel
character
structur
chang
span
throughout
epitheli
line
subepitheli
mesenchym
layer
airway
smooth
muscl
bronchial
vessel
pathophysiolog
pattern
aris
intric
network
interact
genet
environment
factor
includ
allergen
pollut
infecti
agent
regard
latter
role
inde
intrigu
hypothes
respiratori
infect
addit
promot
develop
exacerb
asthma
might
also
exert
protect
effect
diseas
atopi
therefor
aim
review
provid
synthet
updat
complex
relationship
asthma
respiratori
infect
caus
either
virus
bacteria
children
adult
viral
infect
airway
may
associ
develop
chronic
asthma
well
acut
diseas
exacerb
associ
reliabl
confirm
current
avail
diagnost
molecular
tool
enzymat
amplif
viral
nucleic
acid
polymeras
chain
reaction
pcr
although
pcr
yet
wide
use
routin
medic
practic
techniqu
use
identifi
respiratori
virus
especi
perform
sampl
induc
sputum
thu
much
effici
tradit
serolog
immunofluoresc
regard
pathogenesi
asthma
exacerb
commonli
involv
virus
includ
respiratori
syncyti
viru
rsv
rhinoviru
rv
influenza
parainfluenza
virus
coronaviru
enteroviru
adenoviru
wheezingassoci
viral
infect
character
agerel
distribut
particular
rsv
predomin
children
year
age
wherea
rv
repres
frequent
caus
infecti
respiratori
ill
affect
older
children
adult
influenza
parainfluenza
virus
affect
age
group
regard
rsv
noteworthi
point
viru
infect
infant
within
first
year
life
almost
age
year
rsv
often
produc
noncompl
infect
upper
airway
nevertheless
case
rsv
caus
sever
bronchiol
frequent
associ
develop
recurr
wheez
asthma
howev
yet
clear
whether
rsv
constitut
direct
caus
asthma
rather
induc
airway
obstruct
exclus
individu
genet
predisposit
asthma
therefor
difficult
establish
whether
bronchiol
caus
rsv
simpli
acceler
onset
asthma
viru
instead
repres
crucial
factor
subsequ
develop
allerg
sensit
character
mani
asthmat
patient
regard
conflict
data
inde
provid
variou
studi
allow
detect
contrast
other
close
relationship
rsvinduc
paediatr
bronchiol
clinic
manifest
atopi
asthma
instanc
stein
colleagu
carri
wide
perspect
investig
children
studi
sinc
earli
infanc
begin
adolesc
author
found
lower
respiratori
tract
infect
caus
rsv
within
first
year
age
though
sever
requir
hospit
associ
increas
risk
wheez
age
howev
risk
subsequ
subsid
progress
thu
result
signific
age
contrari
scandinavian
group
led
sigur
recent
shown
children
contract
sever
rsv
infect
within
first
year
life
experienc
age
year
higher
frequenc
bronchial
obstruct
atop
asthma
compar
children
previous
affect
seriou
bronchiol
moreov
continu
followup
studi
popul
author
confirm
risk
develop
allerg
asthma
persist
age
subject
hospit
first
year
life
bronchiol
produc
rsv
sever
cellular
molecular
mechan
might
contribut
determin
atop
phenotyp
children
adolesc
histori
sever
form
bronchiol
caus
rsv
earli
childhood
inde
rsv
may
respons
increas
risk
allerg
sensit
favour
creation
bronchial
bronchiolar
microenviron
character
high
level
cytokin
repres
import
factor
determin
expans
lymphocyt
cell
primarili
implic
pathogenesi
allerg
process
furthermor
directli
respons
antibodi
class
switch
promot
product
ige
b
lymphocyt
differ
biolog
behaviour
induc
rsv
might
explain
tendenc
children
common
mild
rsv
infect
develop
predominantli
antivir
immun
respons
character
intens
product
interferong
ifng
otherwis
immun
respons
associ
high
level
occur
young
patient
affect
sever
bronchiol
regard
suggest
individu
suscept
develop
allerg
sensit
seriou
respiratori
viral
infect
may
due
genet
factor
particular
genet
determin
delay
physiolog
earli
postnat
immun
deviat
preval
foetal
pattern
toward
matur
phenotyp
could
predispos
amplif
propag
within
airway
inflammatori
event
trigger
respiratori
virus
inhal
allergen
hypothesi
confirm
high
frequenc
recent
shown
popul
korean
children
hospit
sever
rsv
infect
haplotyp
detect
insid
cytokin
gene
cluster
locat
long
arm
chromosom
gene
polymorph
associ
overexpress
within
biolog
context
key
function
like
exert
specif
rsv
glycoprotein
name
protein
g
abl
promot
immun
respons
fact
compar
evalu
consequ
experiment
induc
infect
caus
either
normal
g
proteindefect
strain
rsv
observ
mice
protein
play
essenti
role
produc
airway
inflamm
function
respiratori
impair
evok
wildtyp
rsv
moreov
rsvelicit
activ
antivir
protein
kinas
may
favour
b
cell
isotyp
switch
ige
final
also
relev
rsv
may
contribut
airway
neurogen
inflamm
induc
express
bronchial
receptor
stimul
substanc
p
effect
thu
lead
amplif
proinflammatori
action
substanc
p
releas
sensori
end
unmyelin
cfibr
import
mechan
experiment
support
demonstr
efficaci
monoclon
antibodi
palivizumab
direct
viral
protein
f
reduc
excess
neural
inflamm
found
airway
rsvinfect
rat
differ
children
scholar
age
follow
period
childhood
adolesc
well
adult
viral
upper
respiratori
tract
infect
involv
asthma
exacerb
caus
rv
therefor
viru
respons
common
cold
also
exert
relev
pathogen
action
acut
asthma
relaps
clinic
function
point
view
airway
infect
due
particular
rv
strain
serotyp
produc
allerg
patient
recrudesc
asthmat
rhinit
symptom
deterior
respiratori
function
increas
bronchial
hyperrespons
latter
may
persist
sever
week
inde
strongli
evid
rv
addit
infect
upper
airway
may
also
colon
lower
respiratori
tract
preval
locat
rvdepend
tissu
damag
repres
bronchial
epithelium
whose
remark
fragil
typic
asthma
make
particularli
suscept
viral
cytotox
effect
turn
facilit
penetr
allergen
noxiou
agent
thu
trigger
posit
feedforward
circuit
cytopath
action
exert
rv
airway
epitheli
cell
like
constitut
initi
event
asthma
exacerb
induc
viru
airway
epitheli
receptor
rv
strain
intercellular
adhes
also
significantli
contribut
pathogenesi
allerg
inflamm
papi
johnston
shown
rv
abl
upregul
express
via
activ
transcript
factor
nuclear
factorkappa
b
nfkb
therebi
increas
pathogen
potenti
moreov
bianco
colleagu
found
also
cytokin
stimul
airway
epitheli
express
thu
increas
suscept
asthmat
patient
rv
infect
hand
nfkb
also
involv
transcript
activ
mani
gene
encod
proinflammatori
cytokin
chemokin
regard
clear
intracellular
oxid
radic
play
key
role
rvinduc
stimul
nfkb
activ
occur
bronchial
epithelium
recent
advanc
molecular
mechan
underli
pathogen
action
rv
import
therapeut
implic
corticosteroid
reduc
agent
abl
inhibit
activ
transcript
factor
respons
enhanc
express
proinflammatori
gene
encod
adhes
molecul
variou
cytokin
particular
airway
epitheli
cell
react
rv
infect
inflammatori
respons
mediat
increas
biosynthesi
interleukin
il
involv
matur
b
lymphocyt
well
fibroblast
prolifer
recruit
neutrophil
chemotaxi
eosinophil
monocyt
respect
bronchial
epitheli
cell
infect
rv
also
produc
high
amount
chemokin
eotaxin
rant
regul
upon
activ
normal
tcell
express
secret
play
power
chemotact
role
eosinophil
airway
infiltr
furthermor
stimul
epitheli
product
fibroprolif
angiogen
factor
fibroblast
growth
rv
extend
action
subepitheli
layer
thu
contribut
structur
chang
respons
airway
remodel
anoth
essenti
compon
asthma
phenotyp
therefor
rv
affect
function
resid
immuneinflammatori
cell
therebi
address
immun
respons
atop
asthmat
patient
toward
predomin
type
pattern
alreadi
character
increas
secret
subject
concomit
reduc
product
type
cytokin
ifng
may
explain
least
part
defect
antivir
defenc
asthma
also
character
ineffect
present
viral
antigen
contribut
impair
immunolog
mechan
aim
neutral
rv
result
persist
rv
infect
thu
lead
exacerb
asthma
symptom
bronchial
hyperrespons
airway
immun
inflamm
occur
mani
asthmat
patient
amplifi
acut
viral
infect
caus
influenza
virus
latter
often
exacerb
respiratori
symptom
bronchial
respons
allerg
stimuli
util
anim
model
asthma
dahl
colleagu
recent
shown
influenza
viru
induc
pulmonari
chang
last
sever
week
infect
resolut
particular
author
observ
previou
flu
infect
abl
enhanc
cellular
respons
subsequ
allergen
sensit
infer
increas
number
eosinophil
lymphocyt
macrophag
detect
bronchoalveolar
lavag
fluid
balf
obtain
mice
infect
influenza
viru
compar
control
anim
undergo
allergen
sensit
previous
expos
viral
infect
influenza
virus
also
contribut
increas
neural
mediat
bronchial
hyperton
viral
neuraminidas
degrad
sialic
acid
residu
prejunct
muscarin
receptor
inhibit
acetylcholin
releas
postganglion
fibr
cholinerg
autoreceptor
exert
inhibitori
control
vagal
neurotransmiss
therefor
influenza
virusdepend
receptor
dysfunct
respons
exagger
reflex
parasympathet
bronchoconstrict
endotrach
inocul
parainfluenza
viru
induc
anim
model
biolog
histolog
chang
reminisc
asthma
particular
viral
infect
elicit
airway
influx
inflammatori
cell
bronchial
hyperrespons
epitheli
damag
bronchiolar
fibrosi
two
latter
alter
like
due
increas
product
transform
growth
factorb
tgfb
parainfluenza
virusstimul
alveolar
macrophag
fact
well
known
tgfb
fibrogen
properti
also
induc
apoptosi
airway
epitheli
cell
suggest
recurr
parainfluenza
viru
infect
may
contribut
patient
asthma
airway
structur
chang
typic
diseas
least
part
mediat
tgfb
apoptosi
bronchial
epitheli
cell
may
view
host
attempt
limit
viral
replic
time
cell
death
like
major
determin
epitheli
damag
occur
asthma
furthermor
epitheli
loss
might
main
caus
defect
bronchial
synthesi
nitric
oxid
detect
associ
parainfluenza
virusdepend
increas
airway
hyperrespons
regard
role
nonvir
infect
asthma
incept
exacerb
atyp
bacteria
chlamydia
pneumonia
mycoplasma
pneumonia
current
believ
involv
pathogen
chlamydia
pneumonia
c
pneumonia
gramneg
oblig
intracellular
bacterium
entir
depend
energi
produc
infect
host
cell
replic
form
characterist
cytoplasm
inclus
within
respiratori
system
main
cellular
target
pathogen
includ
epitheli
endotheli
cell
well
monocyt
macrophag
c
pneumonia
may
caus
infect
upper
lower
respiratori
tract
furthermor
recurr
andor
persist
respiratori
infect
caus
c
pneumonia
like
implic
develop
worsen
asthma
hand
microbi
agent
character
innat
tendenc
determin
chronic
infect
result
particularli
insidi
frequent
quiescent
nonsymptomat
sever
differ
genet
environment
factor
also
includ
coexist
diseas
smoke
habit
therapeut
use
corticosteroid
contribut
promot
persist
c
pneumonia
infecti
capac
number
epidemiolog
studi
shown
mani
asthmat
patient
high
serum
level
igg
iga
antic
pneumonia
antibodi
consid
marker
persist
infect
particular
hahn
colleagu
first
identifi
consist
associ
wheez
antic
pneumonia
antibodi
titr
subject
respiratori
symptom
moreov
author
also
demonstr
chlamydi
infect
risk
factor
asthma
onset
adult
fact
within
studi
popul
symptomat
asthmat
exhibit
serolog
evid
either
current
recent
infect
caus
c
pneumonia
author
extend
observ
thu
show
adult
patient
recent
diagnos
asthma
exist
serolog
posit
chronic
respiratori
chlamydi
infect
addit
recurr
dyspnoeic
episod
induc
c
pneumonia
may
preced
develop
chronic
asthma
previous
asymptomat
individu
cunningham
et
al
studi
asthmat
children
month
thu
show
c
pneumoniaespecif
secretori
iga
antibodi
nasal
aspir
much
elev
subject
frequent
asthma
exacerb
latter
subgroup
children
also
tend
maintain
longer
pcr
posit
c
pneumonia
indic
chronic
infect
confirm
tight
relationship
link
infect
caus
c
pneumonia
asthma
sever
exacerb
provid
cook
colleagu
demonstr
cohort
asthmat
patient
chronic
sever
form
asthma
correl
high
serum
concentr
antic
pneumonia
igg
iga
antibodi
recent
black
et
al
observ
asthmat
adult
elev
serum
titr
antic
pneumonia
igg
iga
directli
associ
sever
asthma
symptom
well
use
high
dose
inhal
corticosteroid
author
also
detect
invers
correl
antibodi
level
airway
calibr
assess
measur
forc
expiratori
volum
one
second
fev
therefor
argu
chronic
chlamydi
infect
like
associ
marker
asthma
sever
regard
relationship
allergeninduc
infectiondepend
asthma
varieti
von
hertzen
colleagu
investig
asthmat
patient
thu
find
nonatop
subject
diseas
significantli
associ
differ
atop
individu
high
concentr
antic
pneumonia
igg
howev
current
known
whether
associ
respiratori
chlamydi
infect
asthma
causal
coincident
order
settl
controversi
use
contribut
might
provid
studi
perform
asthmat
patient
infect
c
pneumonia
aim
evalu
effect
antibiot
especi
macrolid
regard
black
et
al
show
signific
improv
even
peak
expiratori
flow
asthmat
subject
serolog
posit
chlamydi
infect
treat
week
roxithromycin
mg
bid
subsequ
therapi
cessat
decreas
differ
detect
comparison
asthmat
individu
treat
placebo
furthermor
patient
undergo
treatment
roxithromycin
tendenc
found
though
statist
signific
toward
reduct
asthma
symptom
kraft
colleagu
also
demonstr
chlarithromycin
administ
week
mg
bid
elicit
increas
fev
decreas
bronchial
express
subject
pcrposit
c
pneumonia
pneumonia
eosinophil
level
diminish
induc
sputum
obtain
asthmat
adult
treat
week
chlarithromycin
mg
bid
report
amayasu
et
al
also
found
decreas
airway
hyperrespons
patient
latter
effect
confirm
ekici
colleagu
week
treatment
azithromycin
mg
twice
week
howev
induc
fev
chang
moreov
gotfri
et
al
recent
shown
chlarithromycin
mg
bid
given
week
asthmat
individu
treat
oral
prednison
allow
reduc
steroid
dosag
without
consequ
asthma
symptom
respiratori
function
order
correctli
interpret
data
howev
noteworthi
macrolid
appear
exert
independ
antimicrobi
properti
relev
antiinflammatori
action
last
year
consider
progress
made
understand
cellular
molecular
event
underli
potenti
role
c
pneumonia
asthma
pathogenesi
gener
develop
diseas
induc
chlamydi
infect
depend
immunopatholog
mechan
regard
chlamydi
antigen
member
famili
heatshock
protein
seem
possess
remark
immunogen
proinflammatori
cytopath
properti
immun
respons
protein
like
involv
tissu
damag
caus
recurr
persist
chlamydi
infect
infect
cell
produc
proinflammatori
cytokin
tumour
necrosi
factora
tnfa
airway
asthmat
patient
macrophag
bronchial
epitheli
cell
infect
c
pneumonia
could
continu
repeatedli
releas
antigen
thu
contribut
perpetu
amplifi
chronic
inflamm
well
induc
structur
chang
typic
asthma
activ
nfkb
fact
abl
stimul
transcript
gene
encod
proinflammatori
cytokin
adhes
molecul
import
featur
amino
acid
composit
chlamydi
share
high
homolog
sequenc
analog
human
protein
therefor
bacteri
might
evok
autoimmun
reaction
eventu
persist
even
infect
erad
recent
associ
identifi
adultonset
asthma
specif
antibodi
anoth
chlamydi
antigen
name
regard
interest
point
surprisingli
elev
percentag
asthmat
subject
serolog
neg
chlamydi
infect
exhibit
antibodi
respons
taken
togeth
abovement
immuneinflammatori
pathogen
mechan
trigger
chronic
infect
caus
c
pneumonia
may
thu
increas
airway
suscept
environment
stimuli
allergen
virus
therebi
acceler
asthma
progress
therefor
within
context
antibiot
could
play
import
therapeut
role
excel
discuss
recent
review
blasi
et
al
cazzola
et
al
serolog
epidemiolog
studi
suggest
infect
caus
pneumonia
may
implic
pathogenesi
asthma
also
regard
exacerb
instanc
martin
et
al
evidenc
half
asthmat
patient
pcrdocument
presenc
pneumonia
also
associ
higher
number
tissu
mast
cell
comparison
pcrneg
subject
furthermor
administr
chlarythromycin
mg
bid
week
pcrposit
asthmat
significantli
improv
respiratori
function
pneumonia
may
also
trigger
cytokin
respons
associ
elev
serum
ige
concentr
experiment
anim
model
mice
infect
pneumonia
may
develop
airway
obstruct
inflamm
airway
epithelium
repres
import
tissu
target
pneumonia
vitro
cultur
bronchial
epitheli
cell
respond
experiment
induc
pneumonia
infect
enhanc
synthesi
tnfa
rant
tgfb
increas
cell
cultur
supernat
level
rant
tgfb
inhibit
shown
dakhama
colleagu
treatment
either
erythromycin
dexamethason
impli
airway
macrolid
glucocorticoid
potenti
use
prevent
inflammatori
structur
chang
caus
pneumonia
especi
tgfbinduc
damag
bronchial
epithelium
hygien
hypothesi
asthma
remark
increas
preval
allergi
asthma
occur
last
decad
especi
industri
countri
frequent
attribut
group
factor
whole
refer
socal
hygien
articl
press
hypothesi
theori
presum
lifestyl
western
societi
character
improv
hygien
condit
lower
risk
infect
due
widespread
vaccin
decreas
overcrowd
famili
size
respons
reduc
exposur
microbi
agent
especi
infanc
childhood
result
steril
environ
would
reduc
activ
adapt
immun
stimul
viral
bacteri
infect
inde
virus
promot
product
cytokin
ifng
orient
lymphocyt
differenti
toward
pattern
respons
also
favour
high
dose
bacteri
compon
lipopolysaccarid
lp
activ
innat
immun
system
interact
tolllik
receptor
express
dendrit
cell
moreov
delay
hypersensit
mycobacterium
tuberculosi
associ
low
risk
atopi
therefor
reduc
activ
due
lack
infecti
stimuli
may
contribut
polar
immun
respons
toward
phenotyp
involv
develop
allerg
diseas
asthma
howev
recent
epidemiolog
report
rais
reason
doubt
suppos
protect
role
infect
asthma
incept
develop
instanc
larg
studi
carri
europ
subject
show
direct
rather
invers
correl
number
sibl
presenc
asthma
symptom
function
pulmonari
impair
anoth
investig
perform
sampl
almost
british
children
evid
influenc
pertussi
vaccin
allergi
asthma
relationship
asthma
bacteri
endotoxin
also
quit
intrigu
studi
children
age
famili
histori
atopi
litonjua
et
al
recent
demonstr
exposur
high
concentr
endotoxin
hous
dust
associ
increas
risk
wheez
howev
rapidli
declin
within
year
regard
previou
studi
detect
direct
relationship
inhal
endotoxin
level
exacerb
preexist
asthma
symptom
despit
propos
protect
effect
tubercular
infect
allergi
asthma
correl
found
atopi
delay
sensit
tuberculin
popul
african
children
gambia
hand
intraderm
inject
heatkil
mycobacterium
vacca
perform
camporota
et
al
allerg
asthmat
patient
elicit
signific
chang
regard
earli
late
asthmat
reaction
allergen
challeng
bronchial
hyperrespons
histamin
serum
ige
level
product
peripher
lymphocyt
furthermor
holtzman
colleagu
recent
propos
new
theori
decis
altern
hygien
hypothesi
accord
branch
adapt
immun
respons
would
implic
asthma
pathogenesi
particular
within
genet
predispos
individu
context
asthmat
phenotyp
would
develop
consequ
concomit
activ
allerg
antivir
mechan
inde
respiratori
virus
might
induc
bronchial
epitheli
cell
produc
ifng
thu
favour
creation
within
airway
local
environ
character
immun
pattern
time
inhal
allergen
would
promot
deviat
immun
respons
toward
secretori
profil
mainli
includ
therefor
arm
adapt
immun
system
rather
antagon
reciproc
inhibit
may
contribut
togeth
unveil
amplifi
asthmat
phenotyp
featur
chronic
inflamm
bronchial
hyperrespons
airway
remodel
pathogenet
theori
appear
also
support
abovement
data
obtain
dahl
colleagu
author
inocul
intranas
influenza
viru
mice
subsequ
underw
sever
week
viral
infect
allergen
sensit
experiment
condit
influenza
viru
dramat
increas
secret
ifng
pulmonari
dendrit
cell
thu
induc
strong
respons
latter
potenti
rather
inhibit
expans
lineag
trigger
follow
allerg
challeng
within
genet
mediat
host
suscept
dual
involv
cell
activ
viral
agent
inhal
allergen
respect
may
thu
determin
immuneinflammatori
chang
underli
asthma
take
togeth
consider
keep
mind
complex
asthmat
phenotyp
seem
unlik
increas
preval
asthma
industri
world
may
uniqu
due
reduc
exposur
infect
childhood
howev
controversi
hygien
hypothesi
could
complet
inconsist
probabl
need
revis
refer
limit
group
infecti
agent
toxoplasma
gondii
helicobact
pylori
hepat
viru
latter
appear
fact
play
relev
protect
role
develop
atop
disord
case
grow
bodi
vitro
vivo
evid
corrobor
potenti
util
asthma
prevent
treatment
immunostimulatori
approach
also
base
use
unmethyl
cytosineguanosin
cpg
dinucleotid
deriv
bacteri
genom
cpg
dna
sequenc
potent
induc
immun
respons
howev
could
result
complet
effect
prevent
cure
atopi
asthma
addit
repres
eventu
risk
factor
develop
disord
like
autoimmun
diseas
diabet
respiratori
infect
may
significantli
affect
via
complex
cellular
immunolog
mechan
develop
progress
asthma
also
includ
exacerb
hand
routin
clinic
practic
clearli
indic
infect
often
caus
asthmat
patient
worsen
symptom
deterior
pulmonari
function
therefor
antibacteri
agent
macrolid
fluoroquinolon
may
repres
use
therapeut
tool
limit
durat
sever
asthma
exacerb
induc
atyp
bacteria
like
chlamydia
mycoplasm
moreov
progress
may
achiev
asthma
therapi
pharmacolog
immunolog
research
effort
provid
new
molecul
vaccin
abl
realli
effect
virus
commonli
involv
induc
exacerb
widespread
diseas
